Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Sobo, the emphasis is on medically guided care
Clinical trials demonstrate average weight reductions of approximately 15% with semaglutide 2.4 mg (STEP 1 trial) and 20-22.5% with tirzepatide 10-15 mg (SURMOUNT-1 trial) over 68-72 weeks
HS-10535, a developing oral small molecule GLP-1 receptor agonist, mimics the action of the intestinal hormone GLP-1, stimulating insulin secretion to effectively control blood sugar
Clinical research shows that Ozempic can improve blood sugar levels in adults with type 2 diabetes when paired with a healthful diet and exercise
Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma
US$ 22.41
US$ 29.32
US$ 25.84
US$ 28.01
US$ 22.04
US$ 24.70
US$ 27.64
US$ 20.55
